Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Rectal Neoplasms × Ondansetron × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 5 Nausea 5 Lymphoma, Non-Hodgkin 3 Breast Neoplasms 3 Neoplasms 2 Lymphoma 2 Testicular Neoplasms 1 Sezary Syndrome 1 Rectal Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Nausea and Vomiting 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Neutrophilic, Chronic 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1

Interventions

Oxaliplatin 12 Early Intervention, Educational 11 Radiotherapy 10 Fluorouracil 10 Exercise 9 Counseling 9 Surgical Procedures, Operative 7 Methods 7 Drug Therapy 7 Neoadjuvant Therapy 6 Capecitabine 6 Proctectomy 5 Preoperative Exercise 5 Magnetic Resonance Spectroscopy 5 Leucovorin 5 Laparoscopy 5 Surveys and Questionnaires 4 Standard of Care 4 Psychiatric Rehabilitation 4 Fluorodeoxyglucose F18 4 Bevacizumab 4 X-Rays 3 Transanal Endoscopic Surgery 3 Robotic Surgical Procedures 3 Mastectomy, Segmental 3 Irinotecan 3 Ileostomy 3 Consolidation Chemotherapy 3 Cholecalciferol 3 Chemotherapy, Adjuvant 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03182179 2022-10-17

Hodolar

Ente Ospedaliero Cantonale, Bellinzona

Phase NA Completed

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡